XML 19 R9.htm IDEA: XBRL DOCUMENT v3.25.2
Note 2 - Operating Segment Information
6 Months Ended
Jun. 30, 2025
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

NOTE 2 – Operating Segment Information:

 

The Company manages and reports the following segments:

 

Branded Products segment: Primarily through our signature marketing brands BAMKO® and HPI®, we produce and sell customized merchandising solutions, promotional products and branded uniform programs. Branded products are sold to customers in a wide range of industries, including retail chain, food service, entertainment, technology, transportation and other industries. The segment currently has sales offices in the United States and Brazil, with support services in China and India.

 

Healthcare Apparel segment: Primarily through our signature marketing brands Fashion Seal Healthcare®, Wink® and CID Resources, we manufacture (through third parties or in our own facilities) and sell a wide range of healthcare apparel, such as scrubs, lab coats, protective apparel and patient apparel. This segment sells its products to healthcare laundries, dealers, distributors and retailers primarily in the United States.

 

Contact Centers: Through multiple The Office Gurus® entities, including our subsidiaries in El Salvador, Belize, Dominican Republic, the United States and Jamaica until its closure on June 15, 2025, we provide outsourced, nearshore business process outsourcing, contact and call-center support services to North American customers.

 

Intersegment eliminations include the elimination of revenues and costs from services provided by the Contact Centers segment to the Company’s two other segments. Such costs are recognized as selling and administrative expenses in the Branded Products and Healthcare Apparel segments. Income and expenses related to corporate functions that are not specifically attributable to an individual reportable segment are presented within Other in the table below.

 

The chief operating decision maker, who is the Company’s Chief Executive Officer, evaluates the performance of our segments. Segment EBITDA is the profitability metric reported to the Company’s CODM for purposes of making decisions about allocation of resources to, and assessing performance of, each reportable segment. Segment EBITDA is calculated as net sales less cost of goods sold and selling and administrative expenses. Segment information for total assets is not presented as this information is not used by the Company’s CODM in measuring segment performance or allocating resources between segments.

 

The following tables set forth financial information related to the Company’s operating segments (in thousands):

 

  

Branded Products

  

Healthcare Apparel

  

Contact Centers

  

Intersegment Eliminations

  

Other

  

Total

 

For the Three Months Ended June 30, 2025:

                        

Net sales

 $92,647  $28,253  $23,977  $(832) $-  $144,045 

Cost of goods sold

  59,631   18,237   11,364   (513)  -   88,719 

Gross margin

  33,016   10,016   12,613   (319)  -   55,326 

Selling and administrative expenses

  25,432   10,078   11,612   (319)  5,437   52,240 

Depreciation and amortization

  1,395   854   639   -   90   2,978 

Segment EBITDA(1)

 $8,979  $792  $1,640  $-  $(5,347) $6,064 
                         
  

Branded Products

  

Healthcare Apparel

  

Contact Centers

  

Intersegment Eliminations

  

Other

  

Total

 

For the Three Months Ended June 30, 2024:

                        

Net sales

 $81,296  $26,592  $24,832  $(984) $-  $131,736 

Cost of goods sold

  53,170   16,392   11,871   (452)  -   80,981 

Gross margin

  28,126   10,200   12,961   (532)  -   50,755 

Selling and administrative expenses

  22,969   9,879   10,533   (532)  5,715   48,564 

Depreciation and amortization

  1,567   956   753   -   92   3,368 

Segment EBITDA(1)

 $6,724  $1,277  $3,181  $-  $(5,623) $5,559 

 

  

Branded Products

  

Healthcare Apparel

  

Contact Centers

  

Intersegment Eliminations

  

Other

  

Total

 

For the Six Months Ended June 30, 2025:

                        

Net sales

 $179,121  $55,516  $48,202  $(1,697) $-  $281,142 

Cost of goods sold

  118,418   35,367   22,608   (1,018)  -   175,375 

Gross margin

  60,703   20,149   25,594   (679)  -   105,767 

Selling and administrative expenses

  48,852   19,604   22,533   (679)  12,032   102,342 

Depreciation and amortization

  2,875   1,766   1,361   -   180   6,182 

Segment EBITDA(1)

 $14,726  $2,311  $4,422  $-  $(11,852) $9,607 
                         
  

Branded Products

  

Healthcare Apparel

  

Contact Centers

  

Intersegment Eliminations

  

Other

  

Total

 

For the Six Months Ended June 30, 2024:

                        

Net sales

 $168,364  $55,829  $48,384  $(1,999) $-  $270,578 

Cost of goods sold

  108,497   34,119   22,779   (889)  -   164,506 

Gross margin

  59,867   21,710   25,605   (1,110)  -   106,072 

Selling and administrative expenses

  46,263   19,691   20,954   (1,110)  11,704   97,502 

Depreciation and amortization

  3,067   1,893   1,476   -   184   6,620 

Segment EBITDA(1)

 $16,671  $3,912  $6,127  $-  $(11,520) $15,190 

 

The following table reconciles income before income tax expense to Segment EBITDA (in thousands):

 

  

Three Months Ended June 30,

  

Six Months Ended June 30,

 
  

2025

  

2024

  

2025

  

2024

 

Income before income tax expense

 $1,836  $650  $930  $5,242 

Interest expense

  1,250   1,541   2,495   3,328 

Depreciation and amortization

  2,978   3,368   6,182   6,620 

Segment EBITDA

 $6,064  $5,559  $9,607  $15,190